Predicted protein targets (top 13)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | L3MBTL1 | Q9Y468 | 3/20 | 0.38 |
| ▸ | MTNR1A | P48039 | 5/20 | 0.36 |
| ▸ | MTNR1B | P49286 | 5/20 | 0.36 |
| ▸ | KDM4E | B2RXH2 | 2/20 | 0.36 |
| ▸ | SMN1; SMN2 | Q16637 | 2/20 | 0.34 |
| ▸ | SIRT5 | Q9NXA8 | 1/20 | 0.34 |
| ▸ | SSTR4 | P31391 | 1/20 | 0.34 |
| ▸ | POLB | P06746 | 1/20 | 0.34 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.34 |
| ▸ | ATM | Q13315 | 1/20 | 0.34 |
| ▸ | ACHE | P22303 | 1/20 | 0.33 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.33 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.33 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL31583096 | 0.87 | L3MBTL1 (0.40) | L3MBTL1MTNR1AMTNR1BKDM4ESMN1; SMN2 | |
| SCHEMBL31583259 | 0.84 | L3MBTL1 (0.36) | L3MBTL1MTNR1AMTNR1BKDM4ESMN1; SMN2 | |
| SCHEMBL31582832 | 0.84 | SMN1; SMN2 (0.36) | L3MBTL1MTNR1AMTNR1BKDM4ESMN1; SMN2 | |
| SCHEMBL31582800 | 0.83 | L3MBTL1 (0.35) | L3MBTL1MTNR1AMTNR1BKDM4ESSTR4 | |
| SCHEMBL15687253 | 0.76 | ESR1 (0.35) | L3MBTL1KDM4ESMN1; SMN2ALDH1A1 | |
| SCHEMBL31583078 | 0.74 | L3MBTL1 (0.38) | L3MBTL1MTNR1AMTNR1BKDM4ESMN1; SMN2 | |
| SCHEMBL31583219 | 0.74 | LMNA (0.35) | SSTR4POLBMAPK1ATM | |
| SCHEMBL31583497 | 0.74 | L3MBTL1 (0.36) | L3MBTL1MTNR1AMTNR1BSMN1; SMN2 | |
| SCHEMBL31582995 | 0.73 | MTNR1A (0.36) | L3MBTL1MTNR1AMTNR1BSIRT5POLB | |
| SCHEMBL20565261 | 0.72 | POLB (0.47) | L3MBTL1MTNR1AMTNR1BKDM4ESMN1; SMN2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2025106644-A1 | HETEROCYCLIC COMPOUNDS AS INHIBITORS OF ALPHA-V BETA-1 INTEGRIN | MORPHIC THERAPEUTIC, INC. (US) | 2025-05-22 | — | — | WO | disclosed |